Neuro-Oncology,
Journal Year:
2019,
Volume and Issue:
unknown
Published: Sept. 24, 2019
The
ligands
of
mitochondrial
translocator
protein
(TSPO)
have
been
widely
used
as
diagnostic
biomarkers
for
glioma.
However,
the
true
biological
actions
TSPO
in
vivo
and
its
role
glioma
tumorigenesis
remain
elusive.
Journal of Neuroinflammation,
Journal Year:
2021,
Volume and Issue:
18(1)
Published: Nov. 6, 2021
Microglia
are
emerging
as
critical
regulators
of
neuronal
function
and
behavior
in
nearly
every
area
neuroscience.
Initial
reports
focused
on
classical
immune
functions
microglia
pathological
contexts,
however,
immunological
concepts
from
these
studies
have
been
applied
to
describe
neuro-immune
interactions
the
absence
disease,
injury,
or
infection.
Indeed,
terms
such
'microglia
activation'
'neuroinflammation'
used
ubiquitously
changes
disparate
contexts;
particularly
stress
research,
where
prompt
undue
comparisons
conditions.
This
creates
a
barrier
for
investigators
new
neuro-immunology
ultimately
hinders
our
understanding
effects
microglia.
As
more
seek
understand
role
neurobiology
behavior,
it
is
increasingly
important
develop
standard
methods
study
define
microglial
phenotype
function.
In
this
review,
we
summarize
primary
research
physiological
contexts.
Further,
propose
framework
better
microglia1
chronic
stress.
approach
will
enable
precise
characterization
different
which
should
facilitate
development
microglia-directed
therapeutics
psychiatric
neurological
disease.
Frontiers in Cellular Neuroscience,
Journal Year:
2021,
Volume and Issue:
15
Published: Sept. 13, 2021
Neuroinflammation
is
involved
in
the
onset
or
progression
of
various
neurodegenerative
diseases.
Initiation
neuroinflammation
triggered
by
endogenous
substances
(damage-associated
molecular
patterns)
and/or
exogenous
pathogens.
Activation
glial
cells
(microglia
and
astrocytes)
widely
recognized
as
a
hallmark
triggers
release
proinflammatory
cytokines,
leading
to
neurotoxicity
neuronal
dysfunction.
Another
feature
associated
with
neuroinflammatory
diseases
impairment
blood-brain
barrier
(BBB).
The
BBB,
which
composed
brain
endothelial
connected
tight
junctions,
maintains
homeostasis
protects
neurons.
Impairment
this
allows
trafficking
immune
plasma
proteins
into
parenchyma
subsequent
inflammatory
processes
brain.
Besides
neurons,
activated
also
affect
BBB
integrity.
Therefore,
dysfunction
can
amplify
act
key
process
development
neuroinflammation.
integrity
determined
integration
multiple
signaling
pathways
within
through
intercellular
communication
between
perivascular
(pericytes,
astrocytes,
microglia,
oligodendrocytes).
For
prevention
disruption,
both
cellular
components,
such
molecules
cells,
non-cellular
mediators
released
should
be
considered.
Thus,
understanding
intracellular
that
disrupt
provide
novel
treatments
for
neurological
In
review,
we
discuss
current
knowledge
regarding
underlying
mechanisms
cells.
Journal of Internal Medicine,
Journal Year:
2021,
Volume and Issue:
290(2), P. 310 - 334
Published: Jan. 18, 2021
Abstract
The
critical
role
of
primary
care
clinicians
(PCCs)
in
Alzheimer’s
disease
(AD)
prevention,
diagnosis
and
management
must
evolve
as
new
treatment
paradigms
disease‐modifying
therapies
(DMTs)
emerge.
Our
understanding
AD
has
grown
substantially:
no
longer
conceptualized
a
late‐in‐life
syndrome
cognitive
functional
impairments,
we
now
recognize
that
pathology
builds
silently
for
decades
before
impairment
is
detectable.
Clinically,
first
manifests
subtly
mild
(MCI)
due
to
progressing
dementia.
Emerging
optimism
improved
outcomes
stems
from
focus
on
preventive
interventions
midlife
timely,
biomarker‐confirmed
at
early
signs
deficits
(i.e.
MCI
dementia).
A
timely
particularly
important
optimizing
patient
enabling
the
appropriate
use
anticipated
DMTs.
An
accelerating
challenge
PCCs
specialists
will
be
respond
innovations
diagnostics
therapy
system
not
currently
well
positioned
do
so.
To
overcome
these
challenges,
collaborate
closely
navigate
optimize
dynamically
evolving
face
opportunities.
In
spirit
this
collaboration,
summarize
here
some
prominent
influential
models
inform
our
current
AD.
We
also
advocate
accurate
biomarker‐defined)
doing
so,
consider
issues
related
detecting
emerging
biomarkers
clinic.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(9), P. 5023 - 5023
Published: April 30, 2022
Positron
emission
tomography
(PET)
uses
radioactive
tracers
and
enables
the
functional
imaging
of
several
metabolic
processes,
blood
flow
measurements,
regional
chemical
composition,
and/or
absorption.
Depending
on
targeted
processes
within
living
organism,
different
are
used
for
various
medical
conditions,
such
as
cancer,
particular
brain
pathologies,
cardiac
events,
bone
lesions,
where
most
commonly
radiolabeled
with
18F
(e.g.,
[
Biomarkers in Neuropsychiatry,
Journal Year:
2019,
Volume and Issue:
1, P. 100005 - 100005
Published: Nov. 13, 2019
In
2018,
there
was
a
recent
shift
towards
biological
definition
of
Alzheimer's
disease
(AD),
based
on
biomarkers
measured
in
vivo
even
before
the
onset
clinical
dementia
symptoms.
No
single
biomarker
can
by
itself
accurately
diagnose
AD.
A
combination
assessed
through
imaging
and
cerebrospinal
fluid
(CSF)
yields
better
diagnostic
accuracy.
Although
amyloid
PET
CSF
levels
tau
deposits
are
increasingly
used
AD
trials
to
increase
confidence
enrolled
subjects,
routine
use
these
settings
is
still
premature
because
risk
overdiagnosis,
increased
cost
and/or
invasiveness
assessment
method.
Also,
standardization
measures
across
studies
needed
assure
regulatory
approval.
Exploring
novel
beyond
pathologies,
their
longitudinal
change
continnum
important
research
avenues
for
future.
Cell and Tissue Research,
Journal Year:
2020,
Volume and Issue:
382(1), P. 15 - 45
Published: Sept. 18, 2020
Abstract
The
neurotrophic
factor
BDNF
is
an
important
regulator
for
the
development
of
brain
circuits,
synaptic
and
neuronal
network
plasticity,
as
well
neuroregeneration
neuroprotection.
Up-
downregulations
levels
in
human
blood
tissue
are
associated
with,
e.g.,
neurodegenerative,
neurological,
or
even
cardiovascular
diseases.
changes
concentration
caused
by
altered
dynamics
expression
release.
To
understand
relevance
major
variations
levels,
detailed
knowledge
regarding
physiological
pathophysiological
stimuli
affecting
intra-
extracellular
important.
Most
work
addressing
molecular
cellular
regulation
release
have
been
performed
preparations.
Therefore,
this
review
will
summarize
inducing
BDNF,
mechanisms
regulating
efficacy
release,
with
a
focus
on
cells
originating
from
brain.
Further,
we
discuss
current
about
distinct
eliciting
regulated
under
conditions.
European Journal of Nuclear Medicine and Molecular Imaging,
Journal Year:
2021,
Volume and Issue:
49(1), P. 146 - 163
Published: Jan. 12, 2021
Abstract
The
18
kDa
translocator
protein
(TSPO)
is
a
highly
conserved
located
in
the
outer
mitochondrial
membrane.
TSPO
binding,
as
measured
with
positron
emission
tomography
(PET),
considered
an
vivo
marker
of
neuroinflammation.
Indeed,
expression
altered
neurodegenerative,
neuroinflammatory,
and
neuropsychiatric
diseases.
In
PET
studies,
signal
often
viewed
microglial
cell
activity.
However,
there
little
evidence
support
microglia-specific
expression.
This
review
describes
cellular
sources
functions
animal
models
disease
human
health,
central
nervous
system
A
discussion
methods
analysis
quantification
also
presented.
Overall,
it
appears
that
alterations
their
underpinnings,
functional
significance
such
depend
on
many
factors,
notably
pathology
or
model
under
study,
stage,
involved
brain
regions.
Thus,
further
studies
are
needed
to
fully
determine
how
changes
binding
occur
at
level
ultimate
goal
revealing
potential
therapeutic
pathways.
Frontiers in Neuroscience,
Journal Year:
2022,
Volume and Issue:
16
Published: Feb. 16, 2022
Microglia
and
astrocytes
play
essential
roles
in
the
central
nervous
system
contributing
to
many
functions
including
homeostasis,
immune
response,
blood-brain
barrier
maintenance
synaptic
support.
Evidence
has
emerged
from
experimental
models
of
glial
communication
that
microglia
influence
coordinate
each
other
their
effects
on
brain
environment.
However,
due
difference
cells
between
humans
rodents,
it
is
confirm
relevance
these
findings
human
brains.
Here,
we
aim
review
current
knowledge
microglia-astrocyte
crosstalk
humans,
exploring
novel
methodological
techniques
used
health
disease
conditions.
This
will
include
an
in-depth
look
at
cell
culture
iPSCs,
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(18), P. 10572 - 10572
Published: Sept. 12, 2022
Alzheimer's
disease
(AD)
is
a
progressive
neurodegenerative
disorder;
it
the
most
common
cause
of
dementia
and
has
no
treatment.
It
characterized
by
two
pathological
hallmarks,
extracellular
deposits
amyloid
beta
(Aβ)
intraneuronal
Neurofibrillary
tangles
(NFTs).
Yet,
those
hallmarks
do
not
explain
full
pathology
seen
with
AD,
suggesting
involvement
other
mechanisms.
Neuroinflammation
could
offer
another
explanation
for
progression
disease.
This
review
provides
an
overview
recent
advances
on
role
immune
cells'
microglia
astrocytes
in
neuroinflammation.
In
become
reactive
several
mechanisms
leading
to
release
proinflammatory
cytokines
that
further
neuronal
damage.
We
then
provide
updates
neuroinflammation
diagnostic
markers
investigational
therapeutics
currently
clinical
trials
target